← SynDRA
GSK-650394
SynDRA canonical compound SYN0019926 — structure-anchored drug synonym record
| Primary target(s) | SGK1 |
|---|
| Mechanism of action | Serum/glucocorticoid regulated kinase inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- Serum/glucocorticoid regulated kinase inhibitor
- SGK1 INHIBITOR
- SGK2 INHIBITOR
Cross-references
Synonyms
- SGK-1 inhibitor (prostate cancer), GlaxoSmithKline
- GSK650394
- RefChem:144529
- DTXCID10160023
- MFCD12828779
- UNII-56887611DJ
- DXV
- MLS006010262
- GTPL8040
- orb1305255
- SCHEMBL3767908
- SCHEMBL29368746
- SCHEMBL30753539
- CHEBI:95066
- GLXC-03488
- HMS2043A20
- HMS3413P22
- HMS3653A19
- HMS3677P22
- HMS3743K03
- EX-A2233
- QKB84228
- BDBM50296011
- GSK650934
- s7209
- AKOS024457693
- CCG-265020
- CS-1853
- EBC-216028
- GSK650394?
- NCGC00250410-01
- NCGC00250410-12
- NCGC00250410-15
- AC-32637
- AS-16796
- DA-01459
- HY-15192
- SMR004701335
Look up GSK-650394 in the interactive SynDRA portal →